YC's New Fundraising Model: Uncapped SAFEs and Rapid Growth

Funding Rounds

▤ Summary

RonanRX raised $3.25 million on uncapped SAFEs before taking its first investor meeting. The piece uses that raise to illustrate how Y Combinator’s fundraising process has shifted toward faster, larger early commitments. It also notes that YC now backs companies across hardware, energy, space, biotech, and pharmaceuticals, not just software. The author compares this round to an earlier YC demo day experience and highlights how quickly the company closed its seed round.

$ Funding

$
Amount $3.3M Total raised
□
Date August 31, 2026 Announcement date
◎
Investors Y Combinator Lead investors
▥
Company https://ronanrx.com Funded company

◇ AskAI Classifications

Sectors
HealthTech General Healthcare software Practice Management
Functions
Developer and IT Infrastructure Workflow Orchestration

▦ Linked Companies

RonanRx
$1M to $5M